Learn about the PETITE Study
RONIT PRESSLER, MD,
the PETITE study
welcomes and introduces
you to the PETITE study.
Researchers are looking for new ways to treat newborn babies who are having neonatal seizures.
In the PETITE study, local doctors will test a study drug in newborns whose seizures are not adequately controlled with first line treatments (the first treatment given for a disease). The study drug is approved in Europe for oral and intravenous use as adjunctive therapy to help treat seizures in patients with epilepsy 4 years of age and older.
In the US it is approved for oral use as mono- and add-on therapy in patients with epilepsy 4 years of age and older, and for oral and intravenous use in patients 16 years and older.
If you consider participating with your baby in this study, you would aid important health research.
This website provides information about the PETITE study, a clinical study sponsored by UCB Biopharma SPRL. It is addressing parents of newborn babies with seizures on EEG. Information placed on this digital platform is not intended as a substitute for consultation with your healthcare professional. For further information about the disease described on this website or treatment options of this disease, please consult your treating physician.